FILGOTINIB, A SELECTIVE JAK1 INHIBITOR, INDUCES CLINICAL REMISSION IN PATIENTS WITH MODERATE-TO-SEVERE CROHN?S DISEASE: FINAL ANALYSIS OF THE PHASE 2 FITZROY STUDY
Severine Vermeire 1
Stefan Schreiber 2
R. Petryka 3
Tanja Kuehbacher 4
Xavier Hebuterne 5
Xavier Roblin
Maria Klopocka
Eugen-Adrian Goldis
Maria Wisniewska Jarosinska
Andrey Baranovsky
Robert Sike
Kremana Stoyanova
Chantal Tasset
Annegret Van der Aa
Pille Harrison
1 University Hospitals Leuven, Department of Gastroenterology, Leuven, Belgium
2 Universität Kiel UKSH Medizinische Abt. I, UKSH, Kiel, Germany
3 Gastroenterol., NZOZ Vivamed, Warszawa, Poland, Warsaw, Poland
4 Asklepios Wet Hospital Clinic of Internal Medicine, Dept of gastroenterology, Hamburg, Germany
5 Hospital Arche 2, Hepatogastroenter
Conference
UEG Week 2016
Citation
United European Gastroenterology Journal; 2016: 2 (Supplement 1)
Login to access library content
Do you need help setting up your myUEG account?
Contact us at office@ueg.eu